Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1997 4
1998 4
1999 1
2000 2
2001 6
2002 3
2003 3
2004 3
2005 1
2006 4
2008 5
2009 1
2010 3
2011 3
2012 3
2013 2
2014 4
2015 1
2016 2
2017 2
2018 1
2019 1
2020 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Results by year
Filters applied: . Clear all
Page 1
PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells.
Arrighetti N, Cossa G, De Cecco L, Stucchi S, Carenini N, Corna E, Gandellini P, Zaffaroni N, Perego P, Gatti L. Arrighetti N, et al. Among authors: carenini n. Toxicol Appl Pharmacol. 2016 Nov 1;310:9-19. doi: 10.1016/j.taap.2016.08.005. Epub 2016 Aug 20. Toxicol Appl Pharmacol. 2016. PMID: 27554045
7-Azaindole-1-carboxamides as a new class of PARP-1 inhibitors.
Cincinelli R, Musso L, Merlini L, Giannini G, Vesci L, Milazzo FM, Carenini N, Perego P, Penco S, Artali R, Zunino F, Pisano C, Dallavalle S. Cincinelli R, et al. Among authors: carenini n. Bioorg Med Chem. 2014 Feb 1;22(3):1089-103. doi: 10.1016/j.bmc.2013.12.031. Epub 2013 Dec 22. Bioorg Med Chem. 2014. PMID: 24398383 Free article.
FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models.
Corno C, Stucchi S, De Cesare M, Carenini N, Stamatakos S, Ciusani E, Minoli L, Scanziani E, Argueta C, Landesman Y, Zaffaroni N, Gatti L, Perego P. Corno C, et al. Among authors: carenini n. Biochem Pharmacol. 2018 Jan;147:93-103. doi: 10.1016/j.bcp.2017.11.009. Epub 2017 Nov 16. Biochem Pharmacol. 2018. PMID: 29155058
58 results